EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Transcriptional regulation of EMT transcription factors in cancer

Masao Saitoh

Seminars in Cancer Biology · 2023-12 · 97 · 21-29

DOI: 10.1016/j.semcancer.2023.10.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2023-12. Verfasst von Masao Saitoh. Beteiligte Einrichtung: Center for Medical Education and Sciences, Graduate School of Medicine, University of Yamanashi, Chuo-city, Yamanashi, Japan. Electronic address: msa…. Hauptthemen laut MEDLINE: Transcription Factors, Carcinoma. Die Arbeit wurde bisher 175-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The epithelial-mesenchymal transition (EMT) is one of the processes by which epithelial cells transdifferentiate into mesenchymal cells in the developmental stage, known as "complete EMT." In epithelial cancer, EMT, also termed "partial EMT," is associated with invasion, metastasis, and resistance to therapy, and is elicited by several transcription factors, frequently referred to as EMT transcription factors. Among these transcription factors that regulate EMT, ZEB1/2 (ZEB1 and ZEB2), SNAIL, and TWIST play a prominent role in driving the EMT process (hereafter referred to as "EMT-TFs"). Among these, ZEB1/2 show positive correlation with both expression of mesenchymal marker proteins and the aggressiveness of various carcinomas. On the other hand, TWIST and SNAIL are also correlated with the aggressiveness of carcinomas, but are not highly correlated with mesenchymal marker protein expression. Interestingly, these EMT-TFs are not detected simultaneously in any studied cases of aggressive cancers, except for sarcoma. Thus, only one or some of the EMT-TFs are expressed at high levels in cells of aggressive carcinomas. Expression of EMT-TFs is regulated by transforming growth factor-β (TGF-β), a well-established inducer of EMT, in cooperation with other signaling molecules, such as active RAS signals. The focus of this review is the molecular mechanisms by which EMT-TFs are transcriptionally sustained at sufficiently high levels in cells of aggressive carcinomas and upregulated by TGF-β during cancer progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsCarcinomaHumansGene Expression RegulationEpithelial-Mesenchymal TransitionTransforming Growth Factor betaSnail Family Transcription FactorsZinc Finger E-box-Binding Homeobox 1

Stichwörter der Autor:innen

CancerEMTSignal transductionTranscriptional regulation

Substanzen

Transcription FactorsTransforming Growth Factor betaSnail Family Transcription FactorsZinc Finger E-box-Binding Homeobox 1

Autor:innen und Institutionen

  • Center for Medical Education and Sciences, Graduate School of Medicine, University of Yamanashi, Chuo-city, Yamanashi, Japan. Electronic address: msaitoh-ind@umin.ac.jp.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Saitoh, M. (2023). Transcriptional regulation of EMT transcription factors in cancer. Seminars in Cancer Biology, 97, 21-29. https://doi.org/10.1016/j.semcancer.2023.10.001

Vancouver

Saitoh M. Transcriptional regulation of EMT transcription factors in cancer. Seminars in Cancer Biology. 2023;97:21-29. doi:10.1016/j.semcancer.2023.10.001

BibTeX
@article{Saitoh2023,
  author = {Saitoh, Masao},
  title = {Transcriptional regulation of EMT transcription factors in cancer},
  journal = {Seminars in Cancer Biology},
  year = {2023},
  volume = {97},
  pages = {21--29},
  doi = {10.1016/j.semcancer.2023.10.001}
}
Kostenlos starten →